CSF3 and non-Hodgkin lymphoma: As for patients with NHL, benefits of CY in HSCs mobilization are uncertain, the two RCTs enrolling participants before the year of 2000 to compare the efficacy of CY plus G-CSF versus G-CSF alone did not reach consistent conclusions [49, 51].